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The current epidemic of drug abuse in the
search for means to alter consciousness is only one
of the many ways of altering or transcending
states of awareness (1, 2).1 Many other spiritual
exercises in religion, hypnosis, parachute jumping,
or rock climbing are a few of the possible examples
of the ways known to alter mood and thought and
orientation. In the search for the effects of the
psychedelic drug "trips," many substances have
been explored-nutmeg, furniture polish,, aerosol
freezers, airplane glue, and other bizarre agents.
The word, "psychedelic," coined by Osmond (5)
reifies the "mind-manifesting" process known for
millenia and grants a new prestige and a scientific
aura for what is a psychotoxic process. Man has
inhaled carbonated air emitted from the earth,
rotated thongs in the pectoral muscles until they
wore out. Yoga, with its transcendental meditation
techniques, was an attempt to achieve the psy-
chedelic state. Zen Buddhism is construed as a path
for "turning-out" without drugs (3). DeRopp (4)
devised a parlor game which describes a "pathway
to Higher Consciousness Beyond the Drug Experi-
ence." Schizophrenics may experience biochemical
changes which many of the psychotomimetic drugs
are presumed to model. Respiratory failure
(anoxia) due to lack of oxygen in body circulation
may cause hallucination and so will electric stimu-
lation (6).
Osmond (5) originally sought a word in 1957 to
* The authors are indebted to Milton H. Joffee,
Ph.D., National Institute of Mental Health, Division
of Narcotic Addiction and Drug Abuse, and E. Leong
Way, Ph.D., University of California San Francisco,
Department of Pharmacology, for reading the manu-
script and suggesting improvements.
I Numbers in parentheses refer to references following
this article.
replace "psychotomimetic" with one which would
be "euphonious" and not connote a sick mind but
expand and open the mind to man's own nature to
increase his understanding and awareness. He
indicated that specific beneficial goals could be
reached by "unhabitual perception" through
psychedelic drugs. The word "psychedelic" was to
imply good and beneficial effects ... from the use
of compounds like LSD.
LSD was an accidental discovery of an extraor-
dinary sort. Its profound and specific hallucino-
genic action led to eager research in many labora-
tories in hope that such studies with psychotomi-
metics would elucidate the psychotic processes. It
led also to a popular mechanics and popular
medicine by those not qualified. Too many young
people have played with the physical and psycho-
logical effects with no capacity to control or
evaluate the experience and its consequence.
While LSD has not been found to be lethal, its
uncontrolled use has subverted many individuals,
and has created an abusiveness in which meaning-
ful research into its potentials as a psychotherapeu-
tic agent is not possible.
The popular cult of psychedelia has been ex-
ploited by the mass media to embrace an antimo-
nian ideology and hair styles, jewelry, and argot.
The ingestion of the drug is only one aspect of
the transvaluation of values and a reorientation
of the individual who seeks to vitalize his life
anew.
Tolan and Linge (6) have compared the syn-
drome of toxic psychosis due to gasoline inhalation
with the so-called "model psychosis" evoked by
mescaline, LSD, and psilocybin. These "psy-
chotomimetic effects" have also been observed by
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Press and Done (7) in deliberate toluene inhalation.
Visual hallucination and euphoria are among the
desired effects sought by glue-sniffers, and these
subjective responses have been noted in a large
number of medical case reports.
What criteria must a substance fulfill psycho-
pharmacologically to be called a psychedelic? Is
"psychedelic" a valid differentiation scientifically
merited or is it merely a public relation labelling
operation? It appears worthwhile to examine some
of the terms used interchangeably. While hallucino-
gens2 include only those drugs which produce
hallucinations, a more general term describing a
whole range of toxic effects on the cerebrum are
called psychotoxic or psychotogenic. These may
not only include "trips" accommodated by the
exogenous drugs such as mescaline, LSD, Can-
nabis, and barbiturates, but also by a wide range
of anesthetics and commercial organic solvents. A
lack of air and water in toxic amounts may also be
considered psychotoxic.
In comparison to the terms psychotoxic and
psychotogenic, the terms psychotropic and psycho-
active have also been used to cover the spectrum
of drugs and chemicals having an affinity for
cerebral processes without invidious inferences.
"Psychotomimetics" was introduced by Gerard
(9) and applied to those agents reproducing
characteristics of functional psychosis. To be
classed as a psychotomimetic, the drug must only
mimic the syndromes of a psychiatric illness and
"its action must be both readily reversible and of
limited duration" (10).
Psychotomimetic agents have been described as
being capable of effecting changes in perception,
emotion, thought, and ego function (11). These
changes are differentiated from the deliriant effects
elicited by alcohol, morphine, cocaine, and
atropines since these latter compounds tend to
cloud consciousness and exhibits other serious
disability of the autonomic nervous system (12);
the definition of psychotomimetics therefore also
excludes anesthetics, analgesics, and hypnotics.
Ilett and Parfitt (13) categorized the psychoto-
mimetics into four groups: phenylethylamines,
(e.g., mescaline), indoles (e.g., LSD, bufotenine),
piperidines (e.g., phenycyclidine), and cannabinols
(for marihuana).
2See Comprehensive Drug Abuse Prevention and
Control Act of 1970, 21 U.S.C. §§801-966 (1970), in
which 17 hallucinogens, including LSD, mescaline,
marihuana, MDA, DMT, psilocybin, are specifically
listed as controlled drugs.
Osmond (14) defined psychedelic as a compound
"like LSD or mescaline which enriches the mind
and enlarges the vision. It is this kind of experience
which provides the greatest possibility for examin-
ing those areas to psychiatry and which has pro-
vided men down the ages with experiences they have
considered valuable above all others." While psy-
chotomimetic refers to psychological changes re-
sembling, more or less, experiences like those found
in psychotic illnesses, psychedelic implies a benefi-
cial change and the description of a positive value;
however, the word tells more about attitudes
towards drugs than about the effect of the sub-
stance.
The net effect from LSD trips, after all the
confusional experiences have been swept away,
has not elicited any profound revelation. The
overt behavioral change produced by LSD trips
appears to be minimal or non-existent in most
cases. A variety of bizarre, subjective experiences
has been described, but there appears to be no new
insight or true revelations.
PHARMACOLOGICAL BASIS OF COMPAuSON
Since its discovery by Hofmann in 1943, LSD
(lysergic acid iethylamide) has remained the
chemical vehicle for "model psychosis." Its effects
have been used as a basis for comparison with other
substances producing potentials for causing "con-
scious alteration."
LSD belongs to a group of substituted indole
alkylamines. Others in the group include such
psychotomimetics as dimethyltryptamine (DMT),
diethyltryptamine (DET), bufotenine, psilocin,
psilocybin, harmine, and ibogaine. Current reviews
by Hofmann (12) Hoffer and Osmond (14), Down-
ing (15, 16), Crossland (17), Jacobson (18), and
Cohen (11) more than adequately cover the
chemistry and pharmacology of LSD and other
indole hallucinogens.
A cursory examination of the basic structure of
these compounds would reveal their amazing
similarity to serotonin, or 5-hydroxytryptamine
(Fig. 1), an endogenous chemical putatively called
an "inhibitory transmitter" acting between nerve
cells. The presence of serotonin has been theorized
to suppress the brain cells from becoming over-
excited and resulting in hallucination and other
behavioral aberrations.
The specificity of LSD compounds at the nerve
receptor sites introduces another dimensional
interest to the above hypothesis. The brominated
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Serotonin, a putative chemical nerve transmitter, compared with hallucinogenic drugs. LSD, psiocin and
bufotenine possess the same indole ring structure (in bold lines). Mescaline has structure resembling an indole
ring.
derivative of LSD (2-brom LSD), although having
the same serotonin antagonism action, was found
to be devoid of psychotomimetic effects. Moreover,
the levo-rotatory isomer of LSD is relatively
inactive in comparison to the d-form with respect
to serotonin inhibition and devoid of psychotomi-
metic actions. Only the d-LSD form of LSD com-
pounds, therefore, is of interest here.
Also in corroboration to the similarity of the
psychotomimetic activity of indoles is the observa-
tion that psilocybin and psilocin, the simplest
chemical forms of tryptamines indoles yield effects
similar to that of mescaline or LSD. The similarity
of the effects of LSD and psiocybin or psilocin
supported the idea that these two drugs possess
perhaps some common metabolic mechanisms in
causing psychic changes.
Psilocybin and psilocin found in psilocybe
mushrooms, which have been used by Mexican
Indians in elaborate rituals for at least 3000 years,
exert hallucinogenic effects. At high dosage,
mystical or religious experiences are reported by
subjects. That these experiences are different from
what non-Indians report is probably due to a
learning process. One visualizes what one is pre-
pared to see or hear or experience.
The correlation of chemical structure and
psychotomimetic activities of the indoles such as
psilocybin and psilocin and LSD with those of the
most important phenylethylamine, mescaline,
found in the peyote plants are frequently cited in
the literature.
Mescaline, a phenylalkylamine-type compound,
is not a serotonin antagonist nor is it an indole-type
compound that LSD and psilocybin and psilocin
are. Yet it produces in man similar schizophrenic-
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like reactions and also the strange effect of de-
personalization3 with which LSD is characterized.
On closer examination, the chemical structure of
mescaline, 3, 4, 5-dimethoxyphenylethylamine, re-
sembles closely those of indolds (see Figure 1).
Hypothesis has arisen that mescaline is a precursor
to indolic compounds in its eventual action in the
body (13), however, the excretory products from
mescaline use has not been shown to contain an
indole compound (19).
The alteration of mescaline molecule to a 3-
methoxy-4,5-methylene dioxy compound results
in MDA, another psychotomimetic which bears
resemblance to myristicin. The psychotomimetic
effect of nutmeg was suggested by Shulgin (in 20)
to be due to myristicin.
Amphetamine is an isopropylphenethylamine
whose pharmacological action on the CNS is
attributed in part to the free amine. It induces
psychotropic effects if taken in large doses, and
this response is attributed perhaps to the preven-
tion of a putative nerve transmitter called norepi-
nephrine from a re-uptake following its release
from the nerve cells.
That norepinephrine, which is normally present
in the brain, possesses a chemical structure similar
to such psychotomimetic drugs as mescaline and
amphetamines tempts speculations as to its role in
abnormal metabolism in early schizophrenia. For
these reasons, the psychotomimetics have been
valuable in the study of the biochemical function
of the nervous system.
The foregoing brief discussion of the action of,
psychotomimetic drugs has been presented so that
a basis of comparison can be made with the effects
from the inhalation of solvents used in industrial
and household agents with those of LSD.
The "psychedelic" syndromes of LSD ingestion
has been widely documented and reviewed in
journals and exploited in popular literatures (14,
19, 22, 23, 24, 25, 26, 27). Since LSD syndrome is
essentially the same as those for mescaline,
psilocin, and psilocybin it is used as a point of
reference in this discussion.
Table I lists some of the more important sub-
jective effects of LSD in man. It is difficult to
catalog subjective responses since these are idio-
syncracies and are influenced by the individual set,
3The subject feels that he has two forms, an in-
tellectual and emotionless form which is able to ob-
serve the second form, a fantastic being of delusion and
fantasy (13). Spectator and actor in the self, agent
and agency appear fragmented and disintegrated.
by the setting in which the drugs are consumed,
by his prior desires, his traits, his mood, and other
accidental factors. The phantasy of his "psyche-
delic" experience may largely depend on suggested
expectations (4).
MARIUANA
The compilation of bibliography on marihuana,
its chemistry, its ethnopharmacology, and its
social and legal implications, is a major under-
taking (28, 29, 30, 31), so voluminous have been
the published papers.
Polemics and partisanship appear still to be
dominant, and ideological issues contaminate an
objective assessment. Some natural and social
scientists claim that the "weed" is merely a mild
intoxicant or euphoriant while others find it
sufficiently psychoactive to be described as a
psychotomimetic associated with some of the
effects derived from LSD, mescaline, and psilocy-
bin. The various effects are primarily dose-related.
The fact that the active chemical constituents,
THC (tetrahydrocannabinol isomers) are non-
nitrogenous and structurally unrelated and that
no cross-tolerance exists between 1-delta-9 tetra-
hydrocannabinol (from marihuana) and LSD in
man (32), as the latter with mescaline, suggests
that the mechanism of psychotomimetic actions
produced by marihuana and LSD are not funda-
mentally the same. Like LSD, the hallucinogenic
phenomena elicited by Cannabis must be directed,
motivated or situation set, as demonstrated in
controlled experiments by Weil et al (33).
The problem of characterizing marihuana's
pharmacodynamics is in the determination of its
active constituents. The tetrahydrocannabinols
(THC) which were only recently synthesized have
been tentatively assigned the principal active role,
thus opening the door to controlled studies (34,
35). The delta-i isomer of THC is considered the
only important psychotomimetic agent in mari-
huana; the other active THC is called delta-6
THC contained in the marihuana in a quantity ten
times less from that of the delta-i isomer. THC is
extracted from marihuana as an oily fat-soluble
substance. Recent research activities suggest that
THC exerts its action in the animal body as a
more polar metabolite such as hydroxy THC (36).
In man, li-hydroxyl THC and possibly other
polar metabolites of THC appeared to be present
upon administration of THC (37). THC acts in the
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Table I
EFFECTS OF LSD EXPERIENCE OBSERVED IN SOLVENT INHALATION*









Altered shape and color
Sharpened sense of hearing
Synesthesia (rare)
PSYCHIC








































































* From references 6, 7, 56, 61, 65, 71, 72, 73, 74, 75, 76, 77, 78, LSD syndrome according to 79.
manner of other fat soluble substances such as
ether and alcohol but as a steric specific chemical.
Hollister et al (38) tested THC in man and
observed clinical effects resembling those of psy-
chotomimetics such as LSD, but differing in a
longer euphoria, a more pronounced dreamlike
sequence and a prominent sedation. For these
reasons, THC action has been related to that of
alcohol as well as to LSD. Unlike alcohol, however,
marihuana does not induce hangovers even at high
doses. The dosage level used ranged from 30 to 70
milligrams, with a median of 50 milligrams; LSD
dosage, to obtain desired euphoric effects, is about
0.02 to 0.2 milligrams. These and other investiga-
tions have shown that THC induces effects of both
alcohol and LSD, but until more information is
obtained it must be categorized on its own. No
other drug agent, nevertheless, has a more intimate
association with the "psychedelic" community as
has marihuana.
Marihuana ultimately must be evaluated by its
active constituents than by the subjective reports
of behaviors elicited on smoking crude plant
material. Smoking crushed marihuana plant ma-
terial is analogous to smoking crushed opium
poppy pods, both are chemically crude plant tissue
materials containing less than 0.5% active chemical
constituents. The concentrated extracts from
opium poppy and marihuana on the other hand
are what we know as opium and hashish.
On application of heat, the cannabinoids, in-
cluding THC, volatilize and then condense on a
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cool surface. In a simulated smoking experiment
much of the THC has been shown to be trapped
unchanged in the smoking machine (39). One of the
present writers, working in a government testing
laboratory, has detected large amounts of can-
nabinoids in the ashes of burnt cigarettes and in
the stems of smoking pipes indicating that much of
the active constituents of marihuana are trapped
in the smoking paraphernalia, and it is presumed
that only about a half of the active material finds
its way into the body.
Ecological factors may also determine the
strength of marihuana. Plants grown in a warm,
humid climate seem to have a greater THC con-
tent than those grown in a temperature zone. Two
genotypes of marihuana, however, have been
suggested (40), one variety is of the "drug type"
having a higher THC to Cannabidiol ratio than
the "fiber type" having a lower ratio value of
THC.
It should also be noted that much of the seized'
marihuana examined in laboratories contains stalk,
twigs, and seed fragments all of which dilute and
attenuate the psychotropic action of marihuana.
Mold, mildew growth, and insect infestations are
also common. The status of marihuana as a
psychoactive agent must await a less ambiguous
examination of the active principles derived from
information that does not depend on studying the
effect of smoking crushed plant materials. The
availability of synthetic THC affords a chemically
pure product for scientific study and makes
possible an assessment of the full impact of the
effect of marihuana in man.
NmiG
The active constituent of nutmeg remains a
speculative matter. It has been commonly ascribed
to myrlsticin which has been characterized as a
monoamine oxidase enzyme inhibitor like tranyl-
cypromine and iproniazid. Its action is presumed to
increase the level of 5-hydroxytryptamine (sero-
tonin) in the brain and thus perhaps to exert its
narcotic property of inducing stupor (20).
Weil (41) describes reactions from nutmeg
ingestion that range from no change to full-blown
hallucinogenic experiences like those caused by
hashish or LSD. Visual hallucination, distortion of
time and space perception, and body image dis-
tortions have been reported. Feelings of deperson-
alization and unreality have been reported too.
Payne (42) reported on 2 male college students who
ingested about 2 tablespoons of grated nutmeg and
whose clinical symptoms involved exhilaration and
intoxication followed by a persistent feeling of un-
reality for 48 to 60 hours. Payne noted that no
hallucination appeared evident; "the effect is
fairly well known among alcoholic patients and
narcotic addicts whose regular supplies are ex-
hausted."
Farnsworth (43) suggested that the psychotomi-
metic substance must be contained in the volatile
oil of nutmeg, but he doubted, based on lack of
responses in human experiments, that myristicin is
the major psychoactive agent.
At the present time, most writers categorize
nutmeg as "a psychedelic" rather than as an
intoxicant (44) and have indicated that its action
does differ appreciably from that of marihuana
(45). Again, we are faced with the situation where
the active principles must be isolated and fully
characterized.
MORNING GLORY SEEDS
Its abuse was reported by Fink, et al (46) who
noted the similarity to the effects induced by
LSD. D-Lysergic acid monoethyl amide and d-iso-
lysergic acid monoethylamide are the principal
components of morning glory seeds and their
comparative effects with LSD (d-lysergic acid
diethylamide) have been delineated by Barron
(26), Hofman (47) and others. Their psychotomi-
metic effects are somewhat less than those of LSD.
INHALANTS AND Toxic PsycaosEs
The search for euphoria and escape has led
sniffing adolescents to sniff glue solvents, gasoline,
lighter fluids, shoe polish, lacquer, deodorants,
nail polish, laughing gas (nitrous oxide), etc.
4
The social background of glue-sniffing is noted in
an American Social Health Association leaflet by
Winick and Goldstein (48) as well as in a study
conducted in the New York slums by Preble and
Laury (49). An extensive bibliography on glue-
sniffing and other inhalants has been prepared by
Kupperstein and Susman (50) who have also
included newspaper reports. "Ether drinking" (51)
has a historical reference for the "drug abuse" of
the 1890's. Cherkins (52) looks back to 1799 when
the poets Southey and Coleridge used laughing-
4There is a suggestion of the perverted ingestion
known as pica to be considered here as drug users
persist in a smorgasbord of compulsive promiscuous
and indiscriminate pill-popping.
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gas, and Sir Humphrey Davey documented a
vivid description of his experience with laughing
gas that appears to be similar to that elicited by
complex molecules such as LSD and mescaline. It
appears, therefore, that much of the acute effects of
the inhalants are the consequence of a general
CNS depressant.
Case reports (49, 53, 54, 55, 56, 57, 58, 59, 60)
and studied works and reviews (6, 7, 61, 62) indi-
cate transitory but apparent effects resembling the
euphoric, hallucinatory, and other psychic effects
of psychotomimetic drugs.
Although Von Oettringen (63) listed a few of
these psychic responses obtained from a number
of industrial chemicals, ranging from ethanol to
extremely toxic carbon tetrachloride, the literature
is devoid of the psychopharmacological discussion
on industrial solvents. We must therefore rely on
the subjective responses reported retrospectively in
"glue-sniffing" and other deliberate inhalation of
vapor from a limited number of common organic
solvents. The factor of anticipation appears to play
a dominant role in the individual's quest for the
particular desired effect to obtain certain ecstasy
or grandiose power through the use of these
psychoactive agents.
The common agents of purposeful inhalation
include aromatic hydrocarbons (e.g., toluene),
hydrocarbons (e.g., hexane), halogenated hydro-
carbons (e.g., chloroform), ketones (e.g., acetone),
esters (e.g., ethyl acetate), glycols (e.g., ethylene
glycol), and alcohol (e.g., ethyl alcohol). In-
gredients used in some airplane model cements were
listed by Barman, et al (64), Glaser (65), and in the
bulletin on "Glue-Sniffing" issued by the National
Clearinghouse for Poison Control Centers (66);
some of the pathological effects of ingredients
tricresyl phosphate, xylene, toluene, and acetone,
were described. The active component of lighter
fluid is generally naphtha, mixed with other
aliphatic hydrocarbons. Ether, chloroform, and
nitrous oxide in judicious amounts have been used
as anesthetics, however, undesirable side effects
have been present. The difficulty of evaluating
commercially prepared solvents such as glue,
gasoline, and lighter fluid lies in the fact that they
are mixtures, and the subjective effects can not be
attributed to one particular component.
Ethanol, or ethyl alcohol, may be one of the
best inhalants for psychic purposes since it affords
euphoria and mental well-being on prescribed
dosage without the relatively rapid onset of toxic
and other undesirable side-effects. It is conceivable
that other low molecular weight alcohol such as
propanol and butanol used in model airplane
cements would exert similar psychic effects on the
CNS, the higher alcohols with lower vapor pressure
would be relatively weaker. Toluene and benzene,
common ingredients of glue and rubber cements
products, are also shown to induce euphoria.
Diplopia (double visions) was added to the list of
effects since a number of writers have reported
them in glue-sniffing. All in all, the present litera-
ture lacks psychopharmacological studies of indi-
vidual solvents. A description of the toxic mecha-
nism of aromatic hydrocarbons, such as toluene
found commonly in glue, deserves some attention
here.
Toluene is an example of a simple aromatic
hydrocarbon which qualifies as a suitable inhalant
since its odor is not disagreeable, and it has suffi-
cient vapor pressure to effect a rapid onset of
CNS depressant effect.
Contrary to LSD and morphine, the selectivity
or specificity of action of the arematic hydro-
carbons at the CNS site is dependent on the num-
ber of molecules present at the particular moment
rather than the type of molecule. Such physical
effects as the vapor pressure of the solvents in the
cells determine the quality of their action. There-
fore, the depressant action of the alkylbenzenes
(e.g., toluene, xylene) have much in common with
those of alcohol, ketones, ether, and esters.
Benzene compounds with long alkyl chains,
such as having 4 or 5 carbons in the chain, have
little or no CNS depressant action because of low
volatility. Toluene thus is a fast but short acting
agent while such compounds as n-butylbenzene
are slow and long acting. Those with a longer chain
(e.g., phenyldodecane) are less volatile, like mineral
oil, and have no narcotic potency.
The depressant action remains as long as the
hydrocarbons are present in the nerve cells, but,
as soon as these are removed, normal metabolic
activity is restored. Chronic use of these solvents
eventually leads to the degeneration of nerve cells,
particularly in the brain, since these compounds
are fat solvents. During the distribution of these
solvents in the body, the red blood cells absorb
them readily because of their high lipid content,
and there is an accompanying destruction of blood
building tissues and a depletion of oxygen supply.
In chronic cases and in overdoses, the brain re-
ceives an inadequate supply of oxygen which
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results in severe injury. It appears that narcosis
and oxygen depletion go hand in hand. (Narcosis
can occur also with adequate oxygenation.)
As in LSD and marihuana experiences, there
are the suggestions of sexual stimulation associated
with solvent inhalation. Ackerley and Gibson (67)
reported autoerotic and homosexual activity in a
10-year old boy while under lighter fluid induced
euphoria. Gwozdz (68) reported a bizarre case of
the death of a 21-year old male who hanged himself
with a plastic bag and cotton saturated with glue
over his head during masturbation. One need not
assume a pharmacological or physiologic base for
aphrodisiac effects. These may be consequences of
the lowering of inhibition, the "dissolution" of the
superego, or other psychogenic factors.
Glaser (65) discussed a number of materials and
techniques used in inducing what he called "in-
halation psychosis". He noted that possibly "in
some cases, at least, inhalation psychoses may be a
deliriant similar to that induced by barbiturates
and alcohol". If this is so, it is important to infer
that the responses from inhalant experiences differ
from the "psychoses induced by LSD and related
compounds, which is not felt to be a delirium and
which can be differentiated from deliria both
objectively and subjectively".
Glaser remarks that in inhalation psychosis, the
LSD and schizophrenic syndromes may occur only
in individuals "whose psyche was in precarious
balance prior to delirium". Those symptoms de-
scribed by inhalers as auditory, visual, and tactile
hallucinations and spatial distortions, macropsia,
micropsia, and body image distortions may not
develop in all cases.
Gleason et al (69) in Clinical Toxicology of
Commercial Products discuss delirium attributed
to drugs and chemicals and note that certain doses
of LSD, mescaline, atropine, quinacrine, and
especially the amphetamine group produce a
heightening of perception and awareness rather
than a reduction of awareness. However, they
indicate that "in the late stages of severe poisoning
with cerebral exhaustion, these toxic psychoses
(from LSD type drugs) are not distinguishable
from the delirium induced by the commoner seda-
tive drugs".
Acute toxic psychosis is caused by a host of
drugs and other noxae including heavy metal
poisoning, hormones, oxygen depletion, water in
toxic amount as well as glue solvents; they produce
one or more of these disorders: mental clouding,
perceptual disturbances, and impaired motor
activity. All seems to be characterized by clouding
of consciousness and mental disorientation. We
are mindful also of the effects of hypoxia in addi-
tion to the direct effect of solvent inhalation;
Noguchi (70) noted that oxygen is usually excluded
by methods sniffers use. Another possible effect is
that from rising carbon monoxide induced from
deep breathing, if there is re-breathing, it was
stated.
LSD and mescaline appear to be exceptions and
are distinguishable because they may model a
psychotic state in that there is relatively lower
impairment of cognitive functions, consciousness,
memory, or comprehension. Remarkable is the
highly specific and sensitive nature of LSD reaction
since as little as 20 micrograms, or 0.02 gram, can
initiate a train of hallucinatory, euphoric, illu-
sionary reactions with a minimum of mind-cloud-
ing. The LSD effect is long-lived, lasting as long as
12 hours on a single dose.
In short, the toxic inhalants are rapidly absorbed
into the bloodstream, the onset of psychic effect is
rapid, and lasts as long as solvent effect occurs.
Exhilaration, euphoria, and intoxication are the
initial "desirable" effects, but these are rapidly
displaced by headache, dizziness, impaired motor
coordination, nausea, and vomiting. Sustained
use may lead to coma and unconsciousness. Doubt-
lessly, there is a parallel between inhalants and
alcohol drinking with one notable difference being
the rapidity with which such solvents as benzene
and toluene as well as with general anesthetics in
contrast with alcohol reach the CNS. In general,
most inhalants act similar to the anesthetics by
causing disinhibition and general CNS depression.
Table I represents some of the subjective reac-
tions observed in glue sniffing, paint thinners, and
gasoline and are compared to those from LSD
expeiaeces. Since the effects of inhalation psycho-
sis are gleaned mostly from case reports which in
themselves are dependent on subjective recollec-
tions, some of the somatic and psychological
responses may have not been accounted for. While
there are general agreements, such somatic experi-
ences as parasthesia probably went unreported in
glue and thinner sniffing. For the subjective re-
sponses, the element of expectancy is of profound
importance to the extent that it is said that if the
subject is skeptical of the drug effects, he may
suppress all sensory responses. The adolescents
and those from economically impoverished families,
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Table II




















Present, Impairment of cognitive
function
Acute effect, shortlived
Present, confusion & disorientation
Restless, stuporous, irrational, etc.







Relatively none, high order of percep-
tion and alertness
Long (6 to 12 hours)
Not present
Passive-usually, but may exhibit
panic reaction
seeking escape from reality may, on the other hand,
lend themselves to hypersuggestibility of grandiose
illusions. This may be why true hallucination is
said to be of rare occurrence.
It is of interest to note that the inhalant symp-
toms do not include depersonalization, the out-of-
the body experience, which is invariably reported
in LSD experiments. There appears to be no
significant differences in symptoms derived from
the inhalation of the three solvents.
Table II shows the distinctions between the
effects of psychedelic drugs and of glue solvents,
gasoline, and paint thinners. While the two groups
share some of the psychic phenomena, the solvents
do not exhibit the level of consciousness, the
heightened perception, and the hyperalertness of
the LSD experiences. Solvent inhalation leads to a
state of mental deterioration. These features
appear to differentiate the "psychedelic" drugs
from the others.
While some LSD effects overlap those of other
types of drugs such as the bromides, atropines,
barbiturates, and cocaine, LSD appears not to
induce other deleterious effects of toxic psychoses.
The specific effect of the various chemicals on the
brain is poorly understood, but the variety of
psychological reactions obtained by drugs of
different structural configurations indicate that
there are probably specific locations in the brain
even on a cellular or molecular basis which certain
exogenous agents stimulate or depress. Evidently,
LSD affects areas in which the level of conscious-
ness is not diminished, i.e., the cognitive function is
relatively unimpaired. Other compounds possessing
LSD-like effect may include DMT (dimethyl-
tryptamine), DET (diethyltryptamine), bufoten-
ine, psilocybin, psilocin, and possibly tetrahydro-
cannabinol (marihuana).
In contrast, the effect of organic solvents, in-
cluding the alcohols, is that of intoxication at first
but is followed by degenerative action on the nerve
tissues leading to delirium, coma, etc. Gerade (80)
has observed endothelial (fat linings) injuries in
the kidney, liver, spleen, bladder, and thymus as
well as in the brain and spinal cords due to aromatic
'hydrocarbon inhalation. Toxic overdose of the
belladonnas, for example, induces symptoms of
disorientation and deliria.
The term "psychedelia" is now used loosely and
in a figurative sense as a label invoking the prestige
of modern science. -It has suggested factors that
differ from those previously known to us as psycho-
toxic. But as we have noted, the physiological and
behavioral responses subsumed under both the
psychedelic and the psychotoxic labels overlap in
part. The term "psychedelic" has no justified
operational basis, and its use in the place of such
words as psychoactive or psychotropic and hallu-
cinogenic or psychotoxic belong more to the world
of public relations than to that of science. Whether
the state of "psychedelia" is purportedly achieved
by solvent inhalation or by drug ingestion, it
appears quite doubtful if there is a drug or any
other agents which "enriches" the mind and
"enlarges" vision. Succinctly stated by Freedman
(81), "these (psychedelic) drugs do allow the mind
to expand upon and vivify sensations; they shrink




1. The meaning of various terms used to describe
psychopharmacological drugs were compared with
particular reference to the term "psychedelic",
proposed by Humphry Osmond. Terms such as
psychotropic, psychotoxic, psychotogenic, psycho-
active, psychotomimetic, and hallucinogenic have
been used interchangeably to describe the same
group of drugs affecting the central nervous system.
Psychedelic was introduced -in preference to
"psychotomimetic", a term which connotes drugs
which mimic the ill-effects of psychosis. Psycho-
tropic and psychoactive are neutral designations.
2. Some comparisons were made of the effects
of glue solvent sniffing and LSD experience based
on available literatures. Marked differences in
actions were described; the former appear to cause
generalized CNS depression. A transient period of
intoxication is followed by deliria, coma, and, in
some instances, death while the latter evokes a
longer period of intensity, alertness, and keen
sensory perception. The effects of LSD-type drugs,
on the other hand, are induced by a comparatively
small dosage; some of the psychic effects are also a
result of side effects of toxic doses of other chemi-
cals and drug compounds, ranging from bromides
to gasoline to glue solvents. These experiences
differ from those obtained from LSD in the loss
of cognitive function because of their intoxicating
action and/or delirium. In this critical confine,
LSD and LSD-type drugs appear to be differ-
entiated as psychedelics from other chemical
agents which elicit similar subjective effects.
3. It is questionable whether the use of the term
psychedelic in the differentiation of a unique
configuration is now applicable. The connotation
of psychedelic in the semantic sense is that of
bizarre, harmless, and pleasure-giving sensations
while the true experiences from drug-taking are
fraught with psychotoxic reactions and dangers,
both physical and psychic.
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